Hemostemix Closes Private Placement of $469,366
Calgary, Alberta--(Newsfile Corp. - June 17, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")...
Month: June 2025
Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer
Represents Continuation of Long-Running Partnership Focused on Supporting Advancement of Novel Ophthalmic Therapeutic Toward CommercializationCHASKA, Minn., June 17, 2025 (GLOBE...
Eccogene to Report Preclinical Data with ECC4703, Showcasing Impact on Lean Muscle Sparing and Fat Loss in Combination with Semaglutide and Tirzepatide
Late-breaking poster presentation to be reviewed at the upcoming American Diabetes Association’s 85th Scientific SessionsBOSTON and SHANGHAI, June 17, 2025...
Counslr Partners with Hacking HR to Provide 24/7 Mental Health Support for Members
Supporting Professionals Who Are Shaping the Future of WorkNEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Hacking HR, the fastest...
Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East
REHOVOT, Israel and HOBOKEN, N.J., June 17, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical...
Relmada Therapeutics Appoints Urology Expert Raj S. Pruthi, MD as CMO-Urology
Dr. Pruthi brings vast clinical development experience advancing novel therapies for NMIBC to Relmada and the NDV-01 program Phase 3...
Ventyx Biosciences Announces Positive Top-Line Data from its Phase 2a Safety and Biomarker Trial Evaluating VTX3232 in Patients with Early-Stage Parkinson’s Disease
The study met its primary goal of establishing safety and tolerability of VTX3232 in patients with early-stage Parkinson’s disease CSF...
Skye Bioscience to Present Expanded Preclinical CB1 Antibody Data at the American Diabetes Association’s 85th Scientific Sessions
SAN DIEGO, June 17, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on...
Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-101 and Updated Plan for Accelerated Approval in DM1 Following Type C Meeting
- Based on Type C meeting and new data, Dyne submitted revised ACHIEVE trial protocol to FDA elevating vHOT to...
Vireo Growth Inc. Provides Corporate Update Post Closing of All Merger Transactions
MINNEAPOLIS, June 17, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), today announced...
Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville
New name aligns with mission to deliver precision biomarker-based testing for both transplant and oncology careiMDx sponsoring GraftAssureIQ™ research-use-only kits...
Mineralys Therapeutics Announces Positive Topline Results from Phase 2 Explore-CKD Trial of Lorundrostat for the Treatment of Hypertension in Subjects with CKD and Albuminuria
– Explore-CKD met its primary endpoint; lorundrostat 25 mg once daily achieved a 9.3 mmHg reduction in systolic blood pressure,...
ProMIS Neurosciences Presents at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
Webcast of virtual fireside chat today, June 17th, at 7:00 a.m. ETCAMBRIDGE, Massachusetts, June 17, 2025 (GLOBE NEWSWIRE) -- ProMIS...
Tisento Therapeutics Receives U.S. FDA Fast Track Designation for Zagociguat for the Treatment of MELAS
Global Phase 2b PRIZM Study of Zagociguat is Currently Enrolling Participants with MELASCAMBRIDGE, Mass., June 17, 2025 (GLOBE NEWSWIRE) --...
Microbix Attending & Presenting at Asia Pacific POC 2025
Showcasing Global Utility of its QAPs at Point-of-Care Testing ConferenceMISSISSAUGA, Ontario, June 17, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc....
Psyence Biomed Regains Full Compliance with NASDAQ Continued Listing Requirements
New York, New York--(Newsfile Corp. - June 17, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company")...
Beckett’s Launches New Margarita Variety Pack in Time for Summer, Expanding Its Non-Alcoholic Cocktail Line
Rolling Out Nationwide Starting June 18 at Total Wine & More, DrinkBecketts.com, and Select Independent RetailersToronto, Ontario and Los Angeles,...
Breathe BioMedical Launches Second Site in Its Multi-Center Clinical Trial of Its Breath Test for Breast Cancer
Moncton, New Brunswick and Cambridge, Massachusetts--(Newsfile Corp. - June 17, 2025) - Breathe BioMedical, a company developing a breath analytics...
Exobiosphere and Space Cargo Unlimited Unite for High-Throughput Biotech in Space
Paris Air Show, Le Bourget – June 16, 2025 – Booth B46 (Alliance NewSpace Pavilion, Paris Space Hub) PARIS, June...
Aidoc Releases BRIDGE: A New Industry Framework to Guide Safe, Scalable Clinical AI Deployment
Authored by 17 experts across healthcare, academia and technology, BRIDGE offers an open framework for turning AI ideas into real-world...